WHO Engagement With Non-State Actors: No Deal This Year, Work To Continue

Sugar

The annual World Health Assembly closed today following a decision to postpone for one year completion of a new policy on the UN agency’s engagement with industry, foundations and other “non-state actors.”

WHA Committees Approve Plans On Antimicrobial Resistance, Vaccines, Innovation

WHA68 committee action
Photo credit: Eimear Murphy

Today, member states in committee at the World Health Assembly adopted the first global plan of action to address the issue of antimicrobial resistance, and a global plan of action on vaccines. In addition, a mechanism on public health, innovation and intellectual property was postponed until 2022, and a deadline for its evaluation moved to 2018.

WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable

essential meds

The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

WHO Advances R&D Financing Effort; Global R&D Observatory To Launch In January

World Health Assembly Committee B

World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

Review Of WHO Mechanism To Fight Substandard Medicines Postponed Until 2017

bag_of_seized_counterfeit_Viagra

World Health Organization delegates today agreed in committee to postpone until 2017 the review of a mechanism that had been set up to help countries deal with substandard and fake medicines.

WHO Debates Plan To Fight Antibiotic Resistance

using-a-microscope-pv

World Health Organization members this week are debating a plan to address the global problem of increasing resistance to existing antibiotics and the lack of new treatments to replace them. Today, discussions on antimicrobial resistance went to informals to try to resolve outstanding issues.

Two UN Agencies Come Out In Support Of Extension Of TRIPS LDC Waiver

medicines mixed

The United Nations Development Programme and the Joint UN Programme on HIV/AIDS have issued a joint statement supporting a request by least-developed countries to extend a waiver allowing them to abstain from enforcing patents on pharmaceutical products.

Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug

Sovaldi

Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead’s patent applications in five emerging economies.

Statement: Blumenthal Offers Amendment On Trade Transparency

confidential

Senators Blumenthal, Brown, Baldwin, and Udall introduced today a trade negotiation transparency bill that would require that all formal U.S. proposals for trade agreement restrictions on domestic regulations be posted on a website. This is a common sense policy that should be broadly supported. The bill would require policies similar to the transparency policies currently followed by the European Union and by intergovernmental organizations that set similar minimum regulatory standards. But it would be a major change in the current process for trade negotiations followed by the U.S. Trade Representative, which are infamously secretive, write Sean Flynn and David Levine.

WHA68: Global Vaccine Plan Lagging; New Proposal To Lower Prices

68th World Health Assembly Committee A

An assessment of the World Health Organization Global Vaccine Action Plan aimed at delivering vaccination to all and boosting research into new vaccines found implementation to be “far off-track” in some areas. Today at the World Health Assembly, Libya put forward a new proposal at the Assembly to reduce vaccine prices and increase availability in developing countries.